Breaking News - The Fly

Open Search

OPTN

Optinose

$

()

Optinose provides corporate update on XHANCE launch

OPTN

4/25/2024 - 07:25am

Optinose reports preliminary Q1 XHANCE net revenue of $14.9M

OPTN

4/25/2024 - 07:23am

Optinose management to meet virtually with Lake Street

OPTN

3/22/2024 - 04:55am

Optinose management to meet virtually with Lake Street

OPTN

3/19/2024 - 11:14am

Optinose price target raised by $1 at Lake Street, here's why

OPTN

3/18/2024 - 08:49am

OptiNose trading resumes

OPTN

3/15/2024 - 16:20pm

Optinose to resume trading at 4:20 pm ET

OPTN

3/15/2024 - 15:45pm

Optinose says XHANCE nasal spray receives FDA approval

OPTN

3/15/2024 - 15:36pm

OptiNose trading halted, news pending

OPTN

3/15/2024 - 15:26pm

Optinose initiated with bullish view at H.C. Wainwright, here's why

OPTN

3/11/2024 - 06:11am

Optinose reports Q4 EPS (9c), consensus (9c)

OPTN

3/7/2024 - 07:08am

Optinose reports publication of ReOpen Phase 3 trial results

OPTN

1/18/2024 - 12:02pm

Optinose announces 3-month extension of FDA review period for sNDA for XCHANCE

OPTN

12/6/2023 - 07:04am

Optinose participates in a conference call with Jefferies

OPTN

11/10/2023 - 11:50am

Optinose participates in a conference call with Jefferies

OPTN

11/10/2023 - 10:55am